Primary Site >> Colorectal Cancer
Gene >> HNRNPK
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
Ref: Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer. PMID: 16953238 |
Ref: Immunohistochemical detection of HSP27 and hnRNP K as prognostic and predictive biomarkers for colorectal cancer. PMID: 21861207 |
Ref: Heterogeneous nuclear ribonucleoprotein (HnRNP) K genome-wide binding survey reveals its role in regulating 3'-end RNA processing and transcription termination at the early growth response 1 (EGR1) gene through XRN2 exonuclease. PMID: 23857582 |
Ref: Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis. PMID: 25663692 Ref: Heterogeneous nuclear ribonucleoprotein K upregulates the kinetochore complex component NUF2 and promotes the tumorigenicity of colon cancer cells. PMID: 25701787 |
Ref: A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation. PMID: 26804170 |
Ref: Baseline MAPK signaling activity confers intrinsic radioresistance to KRAS-mutant colorectal carcinoma cells by rapid upregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K). PMID: 27793696 Ref: Down-regulation of DAB2IP promotes colorectal cancer invasion and metastasis by translocating hnRNPK into nucleus to enhance the transcription of MMP2. PMID: 28335083 |
Ref: MRPL33 and its splicing regulator hnRNPK are required for mitochondria function and implicated in tumor progression. PMID: 28869607 Ref: Exosomal lncRNA 91H is associated with poor development in colorectal cancer by modifying HNRNPK expression. PMID: 29410604 Ref: Expression levels of hnRNP K and p21WAF1/CIP1 are associated with resistance to radiochemotherapy independent of p53 pathway activation in rectal adenocarcinoma. PMID: 30272263 |